Analyst Reco. LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Market Closed - Nasdaq Other stock markets 21:00:00 21/06/2024 BST			5-day change	1st Jan Change
81.5 ^USD	+1.13%		+1.76%	+43.59%

06-03	Lemaitre Vascular, Inc. Announces Resignation of Lawrence J. Jasinski as A Director	CI
05-31	Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target	05-31	MT
Lemaitre Vascular Insider Sold Shares Worth $9,314,501, According to a Recent SEC Filing	05-08	MT
Lemaitre Vascular Insider Sold Shares Worth $379,991, According to a Recent SEC Filing	05-08	MT
Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating	05-03	MT
Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	04-26	MT
Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	02-28	MT
JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60	23/10/23	MT
Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target	06/09/23	MT
Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63	03/08/23	MT
Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating	02/08/23	MT
Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept	03/05/23	MT
Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating	03/05/23	MT
Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept	03/05/23	MT
Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform	03/05/23	MT
Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform	28/10/22	MT
Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating	29/04/22	MT
Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating	25/02/22	MT
Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating	29/10/21	MT
LEMAITRE VASCULAR : Jefferies Initiates LeMaitre Vascular at Buy Rating With $70 Price Target	16/09/21	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular's Price Target to $58 from $55, Keeps Neutral Rating	03/08/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Analyst Reco.

Filters